| Dr Frank Matthew Abraham, MD | |
|
150 Memorial Drive, Emergecny Department, Kingwood, WV 26537-1141 | |
| (304) 329-1400 | |
| (304) 329-4717 |
| Full Name | Dr Frank Matthew Abraham |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 150 Memorial Drive, Kingwood, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851304364 | NPI | - | NPPES |
| 0045734000 | Medicaid | WV |
| Facility Name | Location | Facility Type |
|---|---|---|
| Preston Memorial Hospital | Kingwood, WV | Hospital |
| Broaddus Hospital Association, Inc | Philippi, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Preston Memorial Hospital Corporation | 5294645107 | 15 |
News Archive
Two new studies, published in The Lancet, reveal for the first time how health in different regions of China has changed in recent decades.
Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
Giving in to your kid's desire for an unhealthy snack may improve your own eating choices, a new University of Alberta study shows.
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain.
› Verified 8 days ago
| Entity Name | Broaddus Hospital Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548246622 PECOS PAC ID: 5991692832 Enrollment ID: O20040413001625 |
News Archive
Two new studies, published in The Lancet, reveal for the first time how health in different regions of China has changed in recent decades.
Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
Giving in to your kid's desire for an unhealthy snack may improve your own eating choices, a new University of Alberta study shows.
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain.
› Verified 8 days ago
| Entity Name | Preston Memorial Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230661 PECOS PAC ID: 5294645107 Enrollment ID: O20040609000164 |
News Archive
Two new studies, published in The Lancet, reveal for the first time how health in different regions of China has changed in recent decades.
Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
Giving in to your kid's desire for an unhealthy snack may improve your own eating choices, a new University of Alberta study shows.
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain.
› Verified 8 days ago
| Entity Name | West Virginia Emergency Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952776379 PECOS PAC ID: 7618270323 Enrollment ID: O20160128002708 |
News Archive
Two new studies, published in The Lancet, reveal for the first time how health in different regions of China has changed in recent decades.
Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
Giving in to your kid's desire for an unhealthy snack may improve your own eating choices, a new University of Alberta study shows.
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank Matthew Abraham, MD 150 Memorial Drive, Emergency Department, Kingwood, WV 26537 Ph: (304) 329-1400 | Dr Frank Matthew Abraham, MD 150 Memorial Drive, Emergecny Department, Kingwood, WV 26537-1141 Ph: (304) 329-1400 |
News Archive
Two new studies, published in The Lancet, reveal for the first time how health in different regions of China has changed in recent decades.
Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.
Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
Giving in to your kid's desire for an unhealthy snack may improve your own eating choices, a new University of Alberta study shows.
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain.
› Verified 8 days ago
Mr. Dale Meyers, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 S. Price St, C/o Preston Memorial Hospital, Kingwood, WV 26537 Phone: 304-329-1400 Fax: 304-329-1175 |